Susquehanna International Group
RCKTW icon

Susquehanna International Group’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Susquehanna International Group’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,692
Closed -$1.72K – 13540
2025
Q3 		$1.72K Buy
47,692
+5,133
+12% +$200 ﹤0.01% 12179
2025
Q2 		$1.68K Sell
42,559
-77,412
-65% -$3.22K ﹤0.01% 12495
2025
Q1 		$5.64K Buy
+119,971
New +$7.8K ﹤0.01% 12253
2024
Q4 		– Sell
-90,947
Closed -$6.37K – 13150
2024
Q3 		$6.37K Sell
90,947
-79,417
-47% -$6.12K ﹤0.01% 11745
2024
Q2 		$10.3K Buy
+170,364
New +$19.4K ﹤0.01% 11774

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.69B AUM 19.05% 1-Year Est. Return